Medicare Enrolled
Dr. Nirav Shah, MD, MBA
Pain Medicine · Beverly, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Nirav Shah is a pain medicine specialist in Beverly, MA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 6,783 Medicare services across 2,164 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $5,713 from 37 pharmaceutical and/or device companies across 188 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 8% volume in MA
$5,713 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,783
Medicare services
Top 8% in MA for pain medicine
2,164
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~484 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,341 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,017 | $103 | $375 |
| Contrast dye for imaging, lower concentration | 277 | $0 | $50 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
248 | $1 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
151 | $134 | $850 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
150 | $0 | $35 |
| Injection, propofol, 10 mg | 142 | $0 | $35 |
| Injection, fentanyl citrate, 0.1 mg | 141 | $1 | $20 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
123 | $231 | $2,000 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
90 | $59 | $180 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
90 | $71 | $300 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
82 | $213 | $2,024 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
81 | $109 | $2,000 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
77 | $220 | $2,182 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
70 | $97 | $2,000 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
63 | $544 | $2,500 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
63 | $303 | $2,500 |
| Anesthesia for spine nerve destruction procedure Administration of anesthesia during a procedure to destroy nerves in the lower back or spinal cord, guided by imaging. |
62 | $92 | $3,648 |
| Anti-nausea injection (ondansetron/Zofran) | 44 | $0 | $1 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
43 | $173 | $3,023 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
43 | $216 | $2,000 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
43 | $110 | $2,000 |
| Anesthesia for nerve block and injection, prone position Administration of anesthesia during a nerve block or injection procedure while the patient is lying face down. |
41 | $96 | $3,868 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
40 | $222 | $2,000 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
31 | $59 | $1,069 |
| Anesthesia for spine nerve destruction procedure Anesthesia provided during a procedure to destroy nerves in the neck or upper back spine. The procedure is performed through the skin using imaging guidance. |
30 | $96 | $3,618 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
26 | $26 | $260 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
23 | $70 | $400 |
| Anesthesia for shock wave therapy for urinary stones Administration of anesthesia during shock wave lithotripsy to break up urinary system stones without the use of a water bath. |
20 | $110 | $4,712 |
| Anesthesia for nerve block and injection Administration of anesthetic medication to numb a specific nerve or area during a nerve block or injection procedure. |
20 | $70 | $2,632 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $146 | $450 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
20 | $0 | $30 |
| Knee nerve block injection with imaging guidance An injection of anesthetic and/or steroid medication into a nerve branch of the knee, performed using imaging guidance to ensure accurate placement. |
19 | $219 | $2,421 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
18 | $51 | $500 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
17 | $474 | $2,500 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
17 | $282 | $2,500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,713
Total received (2018-2024)
Avg $816/year across 7 years
Top 26% in MA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
188
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,713 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$950
2023
$736
2022
$1,516
2021
$330
2020
$481
2019
$813
2018
$887
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$417
Abbott Laboratories
$173
PAINTEQ LLC
$129
Medtronic, Inc.
$78
Nalu Medical, Inc.
$36
ABBVIE INC.
$35
SPR Therapeutics, Inc
$22
Vertos Medical, Inc.
$21
Spinal Simplicity, LLC
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Top 3 companies account for 75.7% of 2024 payments
All-time payments by company (2018-2024) ›
Spinal Simplicity, LLC
$1,216
Abbott Laboratories
$1,158
Boston Scientific Corporation
$564
Vertos Medical, Inc.
$558
PAINTEQ LLC
$359
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$181
BIONESS INC
$169
Nevro Corp.
$156
Vertiflex, Inc.
$144
Medtronic, Inc.
$127
Scilex Pharmaceuticals Inc.
$106
Collegium Pharmaceutical, Inc.
$101
AbbVie Inc.
$81
IBSA Pharma Inc.
$80
Stimwave Technologies Incorporated
$61
Nalu Medical, Inc.
$59
Saluda Medical Americas, Inc.
$53
BOSTON SCIENTIFIC CORPORATION
$51
PFIZER INC.
$50
Purdue Pharma L.P.
$49
SPR Therapeutics, Inc
$46
Shionogi Inc
$45
ABBVIE INC.
$35
BioDelivery Sciences International, Inc.
$27
Pacira Pharmaceuticals Incorporated
$24
Daiichi Sankyo Inc.
$23
Valinor Pharma, LLC
$22
Ultragenyx Pharmaceutical Inc.
$22
Allergan Inc.
$21
Amgen Inc.
$21
INSYS Therapeutics Inc
$18
Relievant Medsystems, Inc.
$17
Novartis Pharmaceuticals Corporation
$15
Bioventus LLC
$15
Teva Pharmaceuticals USA, Inc.
$13
Medtronic USA, Inc.
$13
Kaleo, Inc.
$13
Top 3 companies account for 51.4% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · Aimovig · Axium Sheath Braided DRG · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Crysvita · Durolane · ETERNA · EVZIO · EXPAREL · Evoke SCS · FLECTOR PATCH · General - Pain Management · HA MINUTEMAN G3-R · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LICART · LYRICA · MOVANTIK · Morphabond ER · Nalu Neurostimulation System · OXYCONTIN · Octrode SCS Leads · PAINTEQ · PROCLAIM · Penta SCS Leads · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · RELISTOR · RELISTOR ORAL · SPECTRA WAVEWRITER · SPRINT PNS System · SUBSYS · SYMPROIC · Senza · SlimTip lead DRG Lead · StimQ Receiver Stimulator Kit Channel A US w Receiver · Stimrouter for Pain · Superion ISS · Superion Indirect Decompression System · Symproic · XTAMPZA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pain medicines within 10 mi
55
Per 100K population
6.8
County median income
$99,431
Nearest hospital
NORTHEAST HOSPITAL CORPORATION
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a clinical cardiology specialist, with above-average Medicare volume (top 8% in MA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Shah performed 3,341 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $5,713 from 37 companies across 188 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other pain medicines in Beverly?
Dr. Shah's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Beverly
Browse pain medicines in Beverly ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in MA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in MA
Which MA pain medicines receive the most from drug and device companies.
By company
Spinal Simplicity, LLC Payments to Doctors
See all physicians who received payments from Spinal Simplicity, LLC.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology